Works cited by this work

48 works

Work: Next-generation nano-biosensors for hepatocellular carcinoma

1. Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

   Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13

   Article202510 citations

   ABIABI:AkademIndex/openalex/2026.other.342311

2. <scp>CHB</scp> patients with <scp>rtA181T</scp>‐mutated <scp>HBV</scp> infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes

   Qiqi Ning, Tongwang Yang, Xianghua Guo +8

   Article20238 citations

   ABIABI:AkademIndex/openalex/2026.other.153332

3. Stimulus Responsive Nanocarrier for Enhanced Antitumor Responses Against Hepatocellular Carcinoma

   Deteng Zhang, Jinxiao Song, Zhenghui Jing +4

   Article20244 citations

   ABIABI:AkademIndex/openalex/2026.other.320112

4. Nanographite‐based fluorescent biosensor for detecting microRNA using duplex‐specific nuclease‐assisted recycling

   Qizhi He, Huaiqing Luo, Lingli Chen +3

   Article20193 citations

   ABIABI:AkademIndex/openalex/2026.other.342280

5. Construction of a dual colorimetric fluorescent imprinting polymer hybrid system for the detection of alpha-fetoprotein based on the multi-FRET effect and modeling of its color response mechanism

   Liuyue Xiao, Tianhao Li, Hui Ling +2

   Article20242 citations

   ABIABI:AkademIndex/openalex/2026.other.328379

6. Analysis of Immune and Inflammatory Microenvironment Characteristics of Noncancer End-Stage Liver Disease

   Yang Wang, Qi Wang, Tong Wang Yang +8

   Article20232 citations

   ABIABI:AkademIndex/openalex/2026.other.342291

7. Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway

   Jia He, Feng Xu, Yanyang Liu +4

   Article20242 citations

   ABIABI:AkademIndex/openalex/2026.other.342299

8. Multifunctional gold nanoparticles: bridging detection, diagnosis, and targeted therapy in cancer

   L Zhuang, Yi Lian, Tiantong Zhu

   Review article20252 citations

   ABIABI:AkademIndex/openalex/2026.other.342312

9. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.342271

10. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342272

11. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342273

12. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342274

13. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342275

14. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342276

15. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342277

16. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342278

17. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342279

18. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342281

19. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342282

20. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342283

21. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342284

22. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342285

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342286

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342287

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.342288